T-cell Receptor α/β Depleted Donor Lymphocyte Infusion

Stopped The study met criteria for stopping due to lack of efficacy per protocol specifications.

Conditions

• Lymphoid Leukemia, Acute
• Myeloid Malignancy
• Plasma Cell Tumor

Interventions

• BIOLOGICAL: T-cell Receptor α/β Depleted Donor Lymphocyte Infusions

Sponsor

Guenther Koehne